Navigation Links
FDA Approves Teflaro for Bacterial Infections
Date:10/29/2010

SILVER SPRING, Md., Oct. 29 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

Teflaro is an antibacterial agent in a class of drugs known as cephalosporins, which act by interfering with the bacterial cell wall.

CABP is a bacterial infection that develops in the lungs of patients who are exposed to the bacteria in their normal environment, and not in the hospital. ABSSSI is a bacterial infection of skin and skin structures that requires antibiotic treatment and may require surgical treatment.

MRSA is a type of staph bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin, and amoxicillin. In the community, most MRSA infections are skin infections. Severe or potentially life-threatening MRSA infections occur most frequently among patients in contact with health care settings, according to the Centers for Disease Control and Prevention.

"These are serious and potentially life-threatening infections for which new treatment options are needed," said Edward Cox, M.D., M.P.H, director, Office of Antimicrobial Products in FDA's Center for Drug Evaluation and Research. "FDA is committed to facilitating new antibiotic drug development."

The safety and effectiveness of Teflaro was evaluated in four, Phase 3 clinical trials in patients ages 18 years and older (two each in CABP and in AB
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , September 18, 2014 ... audience, has updated the incredibly successful Serialisation Countdown calendar ... interactive PDF, available at pharmaserialisation.com shows the ... which they will be coming into force. ... longer a matter of "if", but "when" they will ...
(Date:9/18/2014)... 2014  A $3 million grant from The Glenn ... Michigan to establish a national center of excellence in ... Aging Research at U-M will focus on exploiting and ... effects of aging and postpone diseases in animal models. ... help develop medications that may help people live longer, ...
(Date:9/18/2014)... PLAINSBORO, N.J. , Sept. 18, 2014 ... the National Hemophilia Foundation,s (NHF) new three-year initiative, ... to people with hemophilia and their families/caregivers to ... can impede disease management. The curriculum for the ... Your Provider About Pain , focuses on improving ...
Breaking Medicine Technology:Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 2Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 3
... TARRYTOWN, N.Y., Nov. 2, 2011 Siemens Healthcare Diagnostics ... a partnership aimed at setting new standards in ... of patients, infectious disease states and potential treatment paths. ... make existing Siemens molecular HIV tests compatible with the recently ...
... world leader in diabetes care, announced today that it has ... (DHF), a non-profit organization that raises diabetes awareness and connects ... of the Drive the Switch program, which has motivated more ... and their doctor about options for insulin delivery, like the ...
Cached Medicine Technology:New Siemens - Illumina Partnership Targets Clinical Infectious Disease Testing Using Next-Generation Sequencing 2New Siemens - Illumina Partnership Targets Clinical Infectious Disease Testing Using Next-Generation Sequencing 3Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 2Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 3Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 4Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 5Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 6Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 7
(Date:9/18/2014)... ORLANDO, Fla., and DENVER (PRWEB) September 18, 2014 ... office in Orlando. This new office, managed by Todd ... provide health systems in the southeast with the benefits ... without sacrificing the knowledge and advantage of local project ... regional offices, NexCore has expanded its presence across the ...
(Date:9/18/2014)... September 18, 2014 Once again, Hickman’s ... breakfast restaurants around the Valley to celebrate PJs & ... “World Egg Day”: Friday, October 10, 2014. The “breakfast ... locations to benefit Arizona’s Children Association (AzCA) foster care ... dinner at each participating restaurant on October 10 are ...
(Date:9/18/2014)... are trying to learn more about a condition called ... young athletes. In people with sickle cell trait, ... breakdown that can lead to kidney damage and cardiac ... in the United States collapsed and died during training ... "More student-athletes with sickle cell trait have died ...
(Date:9/18/2014)... decades, researchers have tried to develop broadly effective vaccines ... malaria, and tuberculosis. While limited progress has been made ... available that can protect most people from these devastating ... when vaccines just aren,t working? , At Caltech, Nobel ... problem in a different way. Whereas vaccines introduce substances ...
(Date:9/18/2014)... to support private efforts to provide mental health services ... for similar efforts should federal officials decide to expand ... the VA health system, according to a new RAND ... joint project of philanthropic groups and major academic medical ... and other services to veterans and their families. , ...
Breaking Medicine News(10 mins):Health News:NexCore Group Opens Regional Office in Orlando, Florida 2Health News:October 10th Is 6th Annual PJs & Eggs: Hickman’s Family Farms and Breakfast Restaurants Partner to Benefit Arizona Foster Children 2Health News:Scientists Studying Sickle Cell Trait 2Health News:A new way to prevent the spread of devastating diseases 2Health News:A new way to prevent the spread of devastating diseases 3Health News:A new way to prevent the spread of devastating diseases 4Health News:A new way to prevent the spread of devastating diseases 5Health News:Study provides insight about providing private mental health service to veterans 2Health News:Study provides insight about providing private mental health service to veterans 3
... the U.S., demonstrated both the efficacy and ... with nasal symptoms associated with perennial allergic ... today the U.S. Food and Drug Administration (FDA) ... children aged 2-5,years old for the treatment of ...
... unclear, experts say , , MONDAY, Sept. 22 (HealthDay News) ... to take much longer to get to the hospital when ... new study finds. , The finding suggests that patients without ... critical window for time-sensitive care following a heart attack, the ...
... Cyberonics, Inc. (Nasdaq:,CYBX) today announced that its corporate ... The facility incurred no damage from the ... resulting in the Company operating from its,disaster recovery ... returned to normal, including all shipments and production ...
... experience trouble, study finds , , MONDAY, Sept. 22 (HealthDay ... -- which include Crestor, Lipitor, Pravachol and Zocor -- ... Canadian study indicates. , Delirium is a common, and ... of surgery, according to study lead author Dr. Donald ...
... previously unknown mechanism of immunity suggests that there may ... adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at ... (HSPH). The findings, published in the open-access journal ... development of novel pneumococcal vaccines. (The current vaccine, Prevnar, ...
... Pa., Sept. 22 A group of southeastern,Pennsylvania ... on,Thursday, September 25 at 12:00 PM at their ... maternity care crisis in Pennsylvania, and how a,legislative ... State,Representative Mike Vereb (R-Montgomery) and other legislators from,southeastern ...
Cached Medicine News:Health News:FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old 2Health News:FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old 3Health News:FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old 4Health News:Heart Attack Care Often Delayed for the Poor 2Health News:Heart Attack Care Often Delayed for the Poor 3Health News:Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike 2Health News:Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike 3Health News:Cholesterol Drugs May Raise Post-Op Delirium Risk 2Health News:Cholesterol Drugs May Raise Post-Op Delirium Risk 3Health News:New insights could lead to a better pneumococcal vaccine 2
Fundamental help with all major urologic conditions and diseases, plus time-saving recommendations on important problems....
This easy-to-navigate reference provides clear, current, clinically proven recommendations for diagnosis and treatment of neurologic disorders....
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
... eText is a concise yet complete ... recommendations for cardiovascular disease. In addition ... electronic textbook, a full desktop version ... In addition to the electronic textbook, ...
Medicine Products: